Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.
about
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab.Immunotherapy as a Potential Treatment for Chordoma: a Review.The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic.MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition.Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies.Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trialImmunotherapy biomarkers 2016: overcoming the barriers.Pharmacological and immunological targeting of tumor mesenchymalization.Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition.Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury.A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas.Prognostic significance of expression of epithelial-mesenchymal transition driver brachyury in breast cancer and its association with subtype and characteristics.Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer.Chordoma: The Quest for Better Treatment Options.First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies.Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack.Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.Lymphocyte-Related Inflammation and Immune-Based Scores Predict Prognosis of Chordoma Patients After Radical Resection.
P2860
Q33276007-EF2E4609-8EBE-4A59-8BC7-21C1C224DDC4Q33276035-F329F295-E85C-4E31-B760-0EB22DB0B473Q33276143-05510811-8AF7-497B-81A6-184910939D0BQ36544576-A403A99A-3B73-4D3A-9846-204042B9B4AAQ36821095-539B69E0-02E0-4CA5-A3EE-4D44E9BE2B60Q37330932-EBE0B08A-D02D-4255-B9E8-51B8ABB50544Q37684364-8B9C32E8-7E1E-4ED7-A508-99A78C724AB7Q37713438-2BC0B5ED-65DD-4819-B0EB-7A1C933B2EE8Q39029043-AC6587CE-4D4C-4884-B227-A81C7747680CQ39142273-7586685C-4DF5-4F99-B140-56C36C700072Q39435498-A7BBBBF8-A9F1-4CB8-9D22-C8D8B796751CQ40074028-2B00A54C-294A-4BE7-80BE-F9BA4A64A123Q40533062-05347536-5540-4540-9787-626A4BE45422Q49165680-68058CAB-5487-4041-922F-55E0F2C94AD4Q50941364-0578CD61-22B4-47E7-AB0C-6B1E19EAEFECQ51034581-2066FEAC-4701-434D-AE08-2FE0FE86DC95Q53068022-1F45FD26-C8D8-4D05-BCD1-6E35F35CF3DBQ54974080-38CA981E-3730-4F07-A07A-F995106871B5Q54977578-1B245DE9-9508-4699-94AD-DB6103D1688CQ55406159-AF504A83-5366-4C4E-93D1-FB2EA3CF2A53
P2860
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase I Trial of a Yeast-Based ...... ranscription Factor Brachyury.
@ast
Phase I Trial of a Yeast-Based ...... ranscription Factor Brachyury.
@en
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine
@nl
type
label
Phase I Trial of a Yeast-Based ...... ranscription Factor Brachyury.
@ast
Phase I Trial of a Yeast-Based ...... ranscription Factor Brachyury.
@en
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine
@nl
prefLabel
Phase I Trial of a Yeast-Based ...... ranscription Factor Brachyury.
@ast
Phase I Trial of a Yeast-Based ...... ranscription Factor Brachyury.
@en
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine
@nl
P2093
P2860
P1476
Phase I Trial of a Yeast-Based ...... ranscription Factor Brachyury.
@en
P2093
B Harpreet Singh
Christopher R Heery
Italia Grenga
James L Gulley
Jeffrey Schlom
Jennifer L Marté
Myrna Rauckhorst
Philip M Arlen
Ravi A Madan
Renee N Donahue
P2860
P304
P356
10.1158/2326-6066.CIR-15-0119
P577
2015-06-30T00:00:00Z